Tevogen Inc. (NasdaqGM: TVGN)
Health Care · Biotechnology · US
$6.49
-7.02% today · -78.5% 1Y
Tevogen Inc. (NasdaqGM: TVGN) operates in the Biotechnology industry within the Health Care sector. The company is valued at $109.84M and employs 18 people.
Over the last twelve months the share price has lost 78.5%, trading between 3.64 and 39.50.
Tweenvest scores Tevogen Inc. across four factors: quality 3/100, value 63/100. Its strongest factor is value.
TVGN price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $109.84M
- Revenue (TTM)
- —
- P/E
- —
- EPS
- -6.32
- Dividend yield
- —
- Beta (5Y)
- 0.20
- 52-week high
- $39.50
- 52-week low
- $3.64
- Avg volume (3M)
- —
- Shares outstanding
- 15.74M
- Employees
- 18
- Next earnings
- —
About Tevogen Inc.
Tevogen Bio Holdings Inc. is a clinical-stage biotechnology firm dedicated to developing "off-the-shelf" precision T cell therapies for conditions across virology, oncology, and neurology. Its flagship experimental product, TVGN 489, is a precision T cell therapeutic engineered to address critical unmet needs in patients with acute-risk COVID-19, alongside a specific population experiencing long COVID. The company's operations are headquartered in Warren, New Jersey.
- ISIN
- US88165K2006
- Founded
- 2020
- Listed since
- Jan 5, 2022
- Exchange
- Nasdaq Global Market
- Currency
- USD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Kintor Pharmaceutical LimitedSEHK: 9939 | $112.96M | HK$1.80 | -2.71% |
| Coya Therapeutics, Inc.NasdaqCM: COYA | $112.83M | $4.91 | +2.08% |
| Insight Molecular Diagnostics Inc.NasdaqCM: IMDX | $112.57M | $3.46 | +0.58% |
| Anterogen.Co.,Ltd.KOSDAQ: A065660 | $111.74M | ₩15,040.00 | +2.31% |
| Captor Therapeutics Spolka AkcyjnaWSE: CTX | $109.46M | zł65.50 | -2.24% |
| Vaxart, Inc.OTCPK: VXRT | $106.28M | $0.44 | -3.92% |
| ArcticZymes Technologies ASAOB: AZT | $106.10M | Nkr19.90 | -1.00% |
| BioGend Therapeutics Co., Ltd.TPEX: 6733 | $105.83M | NT$25.10 | +0.60% |
Figures last refreshed Oct 4, 2026.